Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Zeo Scientifix, Inc. is a clinical-stage biopharmaceutical company specializing in regenerative medicine and biologics derived from perinatal sources and blood. Its core products include extracellular vesicle therapies like Zofin and autologous biologics such as Patient Pure X. The company develops innovative treatments for degenerative diseases, aesthetic applications, and pain management, operating research labs and pursuing FDA approvals to expand its market globally.
This description was generated via AI from an annual report. Updated about 1 year ago.